"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...

CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous ...

Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens ...

The US president has imposed a 10 per cent tariff across all Chinese imports into the US and proposed a 25 per cent levy on ...

However, for generic drug makers, which are hardest hit by Chinese tariffs, slim profit margins and high costs may thwart ...

Pfizer CEO Albert Bourla announced the possibility of shifting overseas manufacturing to U.S. plants. This response is due to ...